In the present study, the prevalence rates of ADA in all subjects and in patients with atypical depression were 17.77 and 89.54%, respectively, which were compatible with those of our previous reports (Kaiya, 2017; Matsumoto et al., 2020). This evidence concerns the gene ADA and depressive symptom measurement.